• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Provider- and System-Level Barriers and Facilitators to Colonoscopy and Multi-Target Stool DNA for Colorectal Cancer Screening in Rural/Remote Alaska Native Communities.农村/偏远阿拉斯加原住民社区结肠镜检查和多靶点粪便 DNA 用于结直肠癌筛查的提供者和系统层面的障碍和促进因素。
Int J Environ Res Public Health. 2023 Nov 7;20(22):7030. doi: 10.3390/ijerph20227030.
2
Colorectal cancer screening barriers, facilitators, and promotion recommendations by Alaska Native people who are non-adherent to colorectal cancer screening.
J Rural Health. 2025 Jun;41(3):e70067. doi: 10.1111/jrh.70067.
3
Real-World Adherence to Multi-Target Stool DNA Testing for Colorectal Cancer Among Asian Americans.亚裔美国人对结直肠癌多靶点粪便DNA检测的真实世界依从性
Cancer Control. 2025 Jan-Dec;32:10732748251330695. doi: 10.1177/10732748251330695. Epub 2025 Apr 1.
4
Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.阿拉斯加原住民患者和医疗服务提供者对多靶点粪便DNA检测与结肠镜检查用于结直肠癌筛查的看法。
J Prim Care Community Health. 2019 Jan-Dec;10:2150132719884295. doi: 10.1177/2150132719884295.
5
Barriers and Facilitators to Colorectal Cancer Screening Among Health Fair Attendees in Utah.犹他州健康集市参与者进行结直肠癌筛查的障碍与促进因素
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251316659. doi: 10.1177/21501319251316659.
6
Improving CRC screening in an underserved population: real-world adherence to mt-sDNA testing among the incarcerated in Nebraska, United States.改善服务不足人群的结直肠癌筛查:美国内布拉斯加州监狱服刑人员对线粒体小环状DNA检测的实际依从情况
Curr Med Res Opin. 2025 May;41(5):809-816. doi: 10.1080/03007995.2025.2517696. Epub 2025 Jun 14.
7
Mailed Outreach and Patient Navigation for Colorectal Cancer Screening Among Rural Medicaid Enrollees: A Cluster Randomized Clinical Trial.针对农村医疗补助计划参保者的结直肠癌筛查邮件外展与患者导航服务:一项整群随机临床试验
JAMA Netw Open. 2025 Mar 3;8(3):e250928. doi: 10.1001/jamanetworkopen.2025.0928.
8
Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy.临床实践中的多靶点粪便 DNA 筛查:无论是否曾接受过结肠镜检查,对结直肠肿瘤均具有较高的阳性预测值。
Am J Gastroenterol. 2020 Apr;115(4):608-615. doi: 10.14309/ajg.0000000000000546.
9
Barriers and Facilitators of Colonoscopy Screening Among Latino Men in a Colorectal Cancer Screening Promotion Program.结直肠癌筛查推广项目中拉美裔男性结肠镜筛查的障碍和促进因素。
Am J Mens Health. 2023 May-Jun;17(3):15579883231179325. doi: 10.1177/15579883231179325.
10
Factors Influencing the Choice Between Multi-Target Stool DNA and Colonoscopy for Colorectal Cancer Screening Among Alaska Native Peoples.阿拉斯加原住民中影响多靶点粪便DNA检测与结肠镜检查用于结直肠癌筛查选择的因素
Life (Basel). 2025 Jan 17;15(1):120. doi: 10.3390/life15010120.

引用本文的文献

1
Cost of colorectal cancer screening in two tribal health organizations in Alaska.阿拉斯加两个部落卫生组织中结直肠癌筛查的成本。
Cancer Causes Control. 2025 Jul 23. doi: 10.1007/s10552-025-02036-w.
2
Types of Racism and Health Disparities and Inequalities among Cancer Patients: An Editorial Reflection of Articles in This Special Issue of .癌症患者中的种族主义类型及健康差异和不平等:本特刊文章的社论反思
Int J Environ Res Public Health. 2024 Jun 17;21(6):785. doi: 10.3390/ijerph21060785.

本文引用的文献

1
Elevated colorectal cancer incidence among American Indian/Alaska Native persons in Alaska compared to other populations worldwide.与全球其他人群相比,阿拉斯加的美国印第安人/阿拉斯加原住民的结直肠癌发病率较高。
Int J Circumpolar Health. 2023 Dec;82(1):2184749. doi: 10.1080/22423982.2023.2184749.
2
Development of a colorectal cancer screening intervention for Alaska Native people during a pandemic year.在大流行年份为阿拉斯加原住民开发结直肠癌筛查干预措施。
Contemp Clin Trials Commun. 2022 Oct 10;30:101016. doi: 10.1016/j.conctc.2022.101016. eCollection 2022 Dec.
3
Characteristics of colorectal cancers among Alaska Native people before and after implementing programs to promote screening.阿拉斯加原住民实施筛查促进项目前后的结直肠癌特征。
J Cancer Policy. 2021 Sep;29:100293. doi: 10.1016/j.jcpo.2021.100293. Epub 2021 Jul 12.
4
Colorectal cancer community engagement: a qualitative exploration of American Indian voices from North Dakota.结直肠癌社区参与:北达科他州美国印第安人声音的定性探索。
BMC Cancer. 2022 Feb 9;22(1):158. doi: 10.1186/s12885-021-09119-2.
5
Provider-perceived barriers to patient adherence to colorectal cancer screening.提供者所感知到的患者在坚持结直肠癌筛查方面的障碍。
Prev Med Rep. 2021 Dec 27;25:101681. doi: 10.1016/j.pmedr.2021.101681. eCollection 2022 Feb.
6
Adaptation of colorectal cancer screening tailored navigation content for American Indian communities and early results using the intervention.为美国印第安社区量身定制的结直肠癌筛查导航内容的调整及使用该干预措施的早期结果。
Implement Sci Commun. 2022 Jan 28;3(1):6. doi: 10.1186/s43058-022-00253-x.
7
The Indian Health Service and American Indian/Alaska Native Health Outcomes.印第安卫生服务局与美国印第安人/阿拉斯加原住民的健康状况
Annu Rev Public Health. 2022 Apr 5;43:559-576. doi: 10.1146/annurev-publhealth-052620-103633. Epub 2022 Jan 26.
8
Effectiveness of Interventions to Increase Colorectal Cancer Screening Among American Indians and Alaska Natives.提高美国印第安人和阿拉斯加原住民结直肠癌筛查率的干预措施的效果。
Prev Chronic Dis. 2020 Jul 16;17:E62. doi: 10.5888/pcd17.200049.
9
Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.阿拉斯加原住民患者和医疗服务提供者对多靶点粪便DNA检测与结肠镜检查用于结直肠癌筛查的看法。
J Prim Care Community Health. 2019 Jan-Dec;10:2150132719884295. doi: 10.1177/2150132719884295.
10
Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis.评估旨在提高美国结直肠癌筛查率的干预措施:系统评价和荟萃分析。
JAMA Intern Med. 2018 Dec 1;178(12):1645-1658. doi: 10.1001/jamainternmed.2018.4637.

农村/偏远阿拉斯加原住民社区结肠镜检查和多靶点粪便 DNA 用于结直肠癌筛查的提供者和系统层面的障碍和促进因素。

Provider- and System-Level Barriers and Facilitators to Colonoscopy and Multi-Target Stool DNA for Colorectal Cancer Screening in Rural/Remote Alaska Native Communities.

机构信息

Alaska Native Tribal Health Consortium, 3900 Ambassador Dr., Anchorage, AK 99508, USA.

Actionable Data Consulting, P.O. Box 873427, Wasilla, AK 99687, USA.

出版信息

Int J Environ Res Public Health. 2023 Nov 7;20(22):7030. doi: 10.3390/ijerph20227030.

DOI:10.3390/ijerph20227030
PMID:37998261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10671517/
Abstract

The Alaska Tribal Health System is working to increase colorectal cancer (CRC) screening among Alaska Native people, who experience the highest CRC rates in the world. This study examined CRC screening provider- and system-level barriers and facilitators from the perspective of healthcare providers serving Alaska Native people in rural/remote communities. A total of 28 provider (physicians, advanced practice, and Community Health Aides/Practitioners) interviews were held from 1 February to 30 November 2021. Colonoscopy provider-level barrier themes included time, competing priorities, and staffing, while system-level barriers included travel costs, weather, and the COVID-19 pandemic. Multi-target stool DNA (mt-sDNA) barrier themes included test viability and unfamiliarity, and previous stool tests experiences. For both tests, limited medical record reminders was a major barrier. Facilitator themes for both tests included community outreach, cultural competency and patient navigation, and clinic/system improvements. In-depth interviews with tribal health providers showed that adding mt-sDNA testing may help address system-level colonoscopy barriers such as waitlists and travel costs, but other barriers remain. Further research is needed into patient barriers and facilitators, as well as the effectiveness of integrating mt-sDNA into a geographically dispersed tribal health system to reduce cancer disparities and build equity in CRC prevention among Alaska Native people.

摘要

阿拉斯加部落卫生系统正在努力提高阿拉斯加原住民的结直肠癌(CRC)筛查率,他们的 CRC 发病率是世界上最高的。本研究从服务于农村/偏远社区的阿拉斯加原住民的医疗保健提供者的角度,检查了 CRC 筛查提供者和系统层面的障碍和促进因素。总共进行了 28 名提供者(医生、高级实践和社区卫生助手/从业者)的访谈,时间从 2021 年 2 月 1 日至 11 月 30 日。结肠镜检查提供者层面的障碍主题包括时间、竞争优先事项和人员配备,而系统层面的障碍包括旅行费用、天气和 COVID-19 大流行。多靶点粪便 DNA(mt-sDNA)检测的障碍主题包括检测可行性和不熟悉性,以及以前的粪便检测经验。对于这两种检测,有限的医疗记录提醒是一个主要障碍。两种检测的促进因素主题包括社区外展、文化能力和患者导航以及诊所/系统改进。对部落卫生提供者的深入访谈表明,增加 mt-sDNA 检测可能有助于解决结肠镜检查的系统障碍,如候补名单和旅行费用,但其他障碍仍然存在。还需要进一步研究患者的障碍和促进因素,以及将 mt-sDNA 整合到地域分散的部落卫生系统中以减少癌症差异并在阿拉斯加原住民中建立 CRC 预防公平性的有效性。